The identification of pathogenic mutations in the APP, PSEN1, and PSEN2 genes supports the amyloid cascade hypothesis underlying the etiology of AD [1], and verify that these mutations cause early-onset AD due to the abnormal production and accumulation of toxic Aβ species such as Aβ42 and Aβ43 [2, 3]. This evidence concerns the gene APP and Alzheimer disease.